Theravance Biopharma Inc (TBPH)

21.62 +0.20  +0.93% NASDAQ Jul 10, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/07/2020 17:00 EDT Misc Theravance Biopharma Inc First Quarter Earnings Conference Call in 2020
05/07/2020 Earnings Theravance Biopharma Inc First Quarter Earnings in 2020 Release
04/28/2020 15:00 IST Misc Theravance Biopharma Inc Annual General Meeting for 2019
02/27/2020 Misc Theravance Biopharma Inc Annual Report for 2019
02/24/2020 17:00 EST Misc Theravance Biopharma Inc Fourth Quarter Earnings Conference Call for 2019
02/24/2020 Earnings Theravance Biopharma Inc Fourth Quarter Earnings in 2019 Release
11/05/2019 17:00 EST Misc Theravance Biopharma Inc Third Quarter Earnings Conference Call for 2019
11/05/2019 Earnings Theravance Biopharma Inc Third Quarter Earnings in 2019 Release
07/31/2019 08:00 EDT Misc Theravance Biopharma Inc Second Quarter Earnings Conference Call in 2019
07/31/2019 Earnings Theravance Biopharma Inc Second Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.theravance.com
  • Investor Relations URL: http://investor.theravance.com/index.cfm
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: N/A
  • Last Earnings Release: May. 07, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Theravance Biopharma is a diversified biotechnology company that creates medicines to treat serious illnesses. The company's research and development are concentrated primarily on four therapeutic areas-infectious disease, respiratory, gastrointestinal disease, and cardiovascular and renal disease. Its commercial infrastructure is focused primarily on the acute care setting. The company uses strategic collaboration with other industry players. Theravance generates the majority of its revenue in the U.S. and Europe, followed by Asia.

Top Fund Holders

Symbol Name Weighting
SMHCHX ST Healthcare Innovations 8 RE 3.44%
F000013KMT ST Healthcare Innovations 7 CA 2.88%
GSANX Goldman Sachs Small Cap Growth R 1.23%
IHE iShares US Pharmaceuticals ETF 0.47%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.